Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients

NCT03021343 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2018-01-23

Study results available
· View outcomes & findings →

Summary

This study evaluates the role of colchicine in the prevention of atrial fibrillation in patients undergoing open heart surgery. Half of participants will receive colchicine and the other half will not

Conditions

Interventions

DRUG

Colchicine

colchicine given as per trial protocol

Sponsors & Collaborators

  • Jordan Collaborating Cardiology Group

    lead OTHER

Principal Investigators

  • Ramzi A Tabbalat, MD, FACC · Khalidi Hospital and Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-01-31
Completion
2015-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03021343 on ClinicalTrials.gov